EP 1087964 A1 20010404 - N-BENZODIOXANYLMETHYL-1-PIPERIDYL-METHYLAMINE COMPOUNDS HAVING AFFINITY FOR 5-HT RECEPTORS
Title (en)
N-BENZODIOXANYLMETHYL-1-PIPERIDYL-METHYLAMINE COMPOUNDS HAVING AFFINITY FOR 5-HT RECEPTORS
Title (de)
N-BENZODIOXANYLMETHYL-1-PIPERIDYL-METHYLAMINVERBINDUNGEN MIT 5-HT-REZEPTORAFFINITÄT
Title (fr)
COMPOSES DE N-BENZODIOXANYLMETHYL-1-PIPERIDYL-METHYLAMINE PRESENTANT UNE AFFINITE POUR DES RECEPTEURS 5-HT
Publication
Application
Priority
- EP 9903648 W 19990526
- GB 9811879 A 19980603
Abstract (en)
[origin: WO9962902A1] Compounds of formula (I) including pharmaceutically acceptable salts thereof in which R represents H or F, their preparation and their use in the treatment of depression, anxiety, psychoses, Parkinson's disease, obesity, hypertension, Tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, obsessive-compulsive behaviour, panic attacks, eating disorders, anorexia, cardiovascular and cerebrovascular disorders, migraine, non-insulin dependent diabetes melitus, hyperglycaemia, constipation, arrhythmia, disorders of the neuroendocrine system, stress, prostatic hypertrophy, drug-induced extrapyramidal symptoms or spasticity are described.
IPC 1-7
IPC 8 full level
C07D 319/20 (2006.01); A61K 31/443 (2006.01); A61K 31/453 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 9/06 (2006.01); A61P 9/12 (2006.01); A61P 13/08 (2006.01); A61P 15/00 (2006.01); A61P 25/00 (2006.01); A61P 25/06 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); C07D 405/12 (2006.01)
CPC (source: EP KR)
A61K 31/453 (2013.01 - KR); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/06 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 405/12 (2013.01 - EP KR)
Citation (search report)
See references of WO 9962902A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9962902 A1 19991209; AR 018622 A1 20011128; AU 4369599 A 19991220; BG 104988 A 20011130; BR 9910927 A 20010220; CA 2333756 A1 19991209; CN 1304408 A 20010718; CO 5021190 A1 20010327; EP 1087964 A1 20010404; GB 9811879 D0 19980729; HR P20010005 A2 20011231; HU P0102233 A2 20020529; ID 27067 A 20010222; IL 139552 A0 20020210; JP 2002517392 A 20020618; KR 20010052526 A 20010625; NO 20006041 D0 20001129; NO 20006041 L 20001129; PL 344594 A1 20011105; SK 17602000 A3 20010806; TR 200003569 T2 20010420
DOCDB simple family (application)
EP 9903648 W 19990526; AR P990102619 A 19990603; AU 4369599 A 19990526; BG 10498800 A 20001127; BR 9910927 A 19990526; CA 2333756 A 19990526; CN 99806908 A 19990526; CO 99035020 A 19990603; EP 99926434 A 19990526; GB 9811879 A 19980603; HR P20010005 A 20010102; HU P0102233 A 19990526; ID 20002519 A 19990526; IL 13955299 A 19990526; JP 2000552113 A 19990526; KR 20007013670 A 20001202; NO 20006041 A 20001129; PL 34459499 A 19990526; SK 17602000 A 19990526; TR 200003569 T 19990526